原創(chuàng)論文益生菌耐藥性研究進展-在線瀏覽
2024-07-30 08:04本頁面
【正文】 等也有其耐藥性的 少量報導，但本人認為其研究才剛剛起步。總之，無論出于何種原因，作為益生菌都不應該具有耐藥性。 參考文獻 ： [1] Fuller R. Probiotics in man and animals[J]. J Appl Bact, 1989, 66: 365— 378. [2] 顧文杰 , 彭科峰 , 張曉東等 . 益生菌的功效及遺傳修飾 . 生物信息學， 2021， 4: 186189. [3] 陳有容 , 鄭小平 . 益生菌的健康功效及其應用 [J]. 上海水產(chǎn)大學學報， 2021， 10(3): 269— 275． [4] . HamiltonMiller, . Deficiencies in microbioiogical quality and labeling of probiotic supplements. International Journal of Food Microbiology. 2021, 27(12): l75. [5] T. Mattila, Sandholm, P. Myllarinen, R. Crittenden, et al. Technological challenges for future probiotic foods, International Dairy Journa1. 2021, 12(23): 173182. [6] Taksno T. Milk derived peptides and hypertension reduction[J]. Infl DairyJ, 1998, 8: 375381. [7] 鄧小紅 .微生物耐藥性的分子機制研究進展 . 藥學進展 , 2021， 18（ 4）： 36. [8] Lzumi S, Aranishi F. Relationship between gyrA mutations and quinolone resistance in 7 Flavobacterium psychrophilum isolates. Appl Environ Microbiol, 2021, 70(7): 39683972. [9] Macinga DR, Renick PJ, Makin KM, et al. Unique biological properties and molecular mechanism of 5, 6bridged quinolones. Antimicrob Agents Chemother, 2021, 47(8): 25262537. [10] Tran JH, Jacoby GA. Mechanism of plasmidmediated quinolone resistance. Proc Natl Acid Sci USA, 2021, 99(8): 56385642. [11] Davies J, Smith D1. Plasmiddetermined resistance to antimicrobial agents[J]. Annd Rev Microbiol, 1978, 32: 469518. [12] Dorthe S, Frank MA, Lars BJ. Charactefisation of integrons and an tibiotic resistance genes in Dan ish multiresistants Salmonella enterica Typhirnuriurn DT104[J]. FEMS Microbiology Letter 1998, 160: 3741. [13] Mobak KDL, Baggesen FK, Aarestrup JM, et a1. An outbreak of multidrugresistant, quinoloneresistant Salmonella enterica sero type Typhimuriurn DT104[N]. Ensl Med, 1999, 341: 14201425. [14] Corpet DE, Lumeau S, Corpet F. Mimimum antibiotic levels for
畢業(yè)設計相關推薦
鄂ICP備17016276號-1